===
EQS Voting Rights Announcement: Marinomed Biotech AG
Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution
2024-04-15 / 16:00 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018

Wien, 15.4.2024

Overview
? Notification made after deadline
Caution: In case of violations of major holdings notification rules, please pay attention to Section 137 BörseG 2018
(Suspension of voting rights)

1. Issuer: Marinomed Biotech AG
2. Reason for the notification: Acquisition or disposal of voting rights
3. Person subject to notification obligation
Name: LLB Invest Kapitalanlagegesellschaft m.b.H.
City: Wien
Country: Österreich
4. Name of shareholder(s):
5. Date on which the threshold was crossed or reached: 15.4.2024
6. Total positions
% of voting rights through

% of voting rights    financial/other instruments                   Total number of 
attached to shares          (7.B.1 + 7.B.2)          Total of both voting rights of 
(7.A)                                          in % (7.A +        issuer 

7.B)
Resulting situation on the date
on which threshold was crossed / 5,02 % 0,00 % 5,02 % 1 540 530
reached
Position of previous notification
(if applicable) 4,01 % 0,00 % 4,01 %
===
Details

7. Notified details of the resulting situation:

===
A: Voting rights attached to shares

Number of voting rights                    % of voting rights 
ISIN Code          Direct               Indirect               Direct            Indirect 

(Sec 130 BörseG 2018) (Sec 133 BörseG 2018) (Sec 130 BörseG 2018) (Sec 133 BörseG
2018)

ATMARIONOMED6                77 374                     0                5,02 %          0,00 % 
SUBTOTAL A                     77 374                                   5,02 % 

B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018
Number of voting
Type of instrument Expiration Date Exercise Period rights that may be % of voting rights
acquired if the
instrument is exercised

SUBTOTAL B.1
B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018
Type of instrument Expiration Date Exercise Period Physical / Number of % of voting rights
Cash Settlement voting rights

SUBTOTAL B.2
===
8. Information in relation to the person subject to the notification obligation:

? Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

? Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

9. In case of proxy voting

Date of general meeting: -

Voting rights after general meeting: - is equivalent to - voting rights.

10. Sonstige Kommentare:

Die LLB Invest Kapitalanlagegesellschaft m.b.H. hält genannte Aktien als Verwaltungsgesellschaft (KAG) von vier Investmentfonds. Es gilt hinsichtlich der Zurechnung/Kontrolle die Ausnahme nach § 134 Abs 2 BörseG und § 8 TransV 2018.

Wien am 15.4.2024

-----------------------------------------------------------------------------------------------------------------------

2024-04-15 CET/CEST

-----------------------------------------------------------------------------------------------------------------------

===

Language:     English 
Company:      Marinomed Biotech AG 

Hovengasse 25
2100 Korneuburg
Austria
Internet: www.marinomed.com

End of News EQS News Service
===
1880665 2024-04-15 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1880665&application_name=news

END) Dow Jones Newswires

April 15, 2024 10:00 ET (14:00 GMT)